PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Fruit rind administered to mice significantly showed antidepressant and anxiolytic effects via the monoaminergic pathway [PMID:28593516]
Garcinol demonstrates anti-neoplastic effects in various cancer types (e.g., breast, colon, prostate) by inhibiting regulatory pathways, though it remains in the preclinical stage [PMID:27671827, PMID:32365899]
Garcinol promotes wound healing in diabetic mice by regulating inflammation and inhibiting the PI3K/Akt/NF-κB signaling pathway [PMID:40022821]
Animal studies indicate HCA suppresses fatty acid synthesis and induces weight loss, though human clinical findings are controversial [PMID:11754536]
Garcinol Enriched Fraction (GEF) showed effectiveness in treating adjuvant-induced arthritis due to anti-inflammatory properties [PMID:30457056]
Safety & adverse effects
Evidence summary
PubMed sources
- 1.PMID: 22719626 (2012) — (1S,5R,7R,30S)-14-De-oxy-isogarcinol. · Acta crystallographica. Section E, Structure reports online
- 2.PMID: 34959738 (2021) — Pharmacological Activity of Garcinia indica (Kokum): An Updated Review. · Pharmaceuticals (Basel, Switzerland)
- 3.PMID: 27671824 (2016) — Gambogic Acid and Its Role in Chronic Diseases. · Advances in experimental medicine and biology
- 4.PMID: 35933691 (2022) — Bioactive compounds, bio-functional properties, and food applications of Garcinia indica: A review. · Journal of food biochemistry
- 5.PMID: 33034447 (2020) — Garcinol Is an HDAC11 Inhibitor. · ACS chemical biology